Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,869
Total Claims
$858K
Drug Cost
1,007
Beneficiaries
$852
Cost/Patient
Risk Score Breakdown 51/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+2620%
Opioid rate vs peers
70.2% vs 2.6% avg
-20%
Cost per patient vs peers
$852 vs $1,068 avg
-19%
Brand preference vs peers
7.3% vs 9.0% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Opioid Prescribing
70.2%
Opioid Rate
10,431
Opioid Claims
$605K
Opioid Cost
20.0%
Long-Acting Rate
This provider's opioid prescribing rate of 70.2% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 1,085 claims · $416K
Generic: 13,784 claims · $442K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 268 | $126K |
| Hydrocodone/Acetaminophen | 2,579 | $97K |
| Oxycodone Hcl/Acetaminophen | 1,801 | $81K |
| Oxycodone Hcl | 3,000 | $76K |
| Naloxegol Oxalate | 113 | $51K |
| Buprenorphine Hcl | 55 | $49K |
| Oxycodone Hcl | 91 | $40K |
| Morphine Sulfate | 1,214 | $33K |
| Buprenorphine | 84 | $29K |
| Pregabalin | 20 | $24K |
| Naloxone Hcl | 252 | $23K |
| Gabapentin | 843 | $17K |
| Ubrogepant | 14 | $15K |
| Morphine Sulfate | 405 | $14K |
| Fentanyl | 135 | $13K |
Prescribing Profile
50
Unique Drugs
51.0
Anomaly Score
Patient Profile
63
Avg Age
65%
Female
1.63
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About